HOME >> BIOLOGY >> NEWS
Almac Diagnostics announces pioneering genetic research on ductal carcinoma in situ

CRAIGAVON, NORTHERN IRELAND, 8 Aug 2007 Today Almac Diagnostics announced a major study analysing ductal carcinoma in situ tissue samples using its novel Breast Cancer DSA microarray. DSA research tools focus on the transcriptome of an individual disease, in this case breast cancer, and contain significant additional data, relevant to the disease of interest that is not available on other generic microarrays. The study will be conducted in collaboration with Prof Adrian Harris, Cancer Research UK and Professor of Medical Oncology at the University of Oxford.

Our novel technology is helping researchers to reduce discovery timelines, accelerate the validation process and ultimately deliver clinical applications in this disease setting. said Paul Harkin, BSc, PhD, Professor of Molecular Oncology at the Centre for Cancer Research and Cell Biology, Queens University, Belfast and MD and President of Almac Diagnostics.

This particular study aims to generate a gene signature to identify the subset of DCIS patients who are likely to suffer a recurrence, he added.

The study will use paraffin embedded samples and is due to commence in the coming weeks. Tissue samples will be analysed using the Breast Cancer DSA research tool. An Almac bioinformatics team will interrogate the resulting data to identify any potential signature.

Our research will use the Breast Cancer DSA microarray to examine the transcriptome of ductal carcinoma in situ at a greater level of specificity generating additional information that will help us draw meaningful conclusions from our data. Eventually we hope to develop a gene expression signature that will inform clinical treatment strategies" said Prof Adrian Harris, Cancer Research UK Professor of Medical Oncology at the University of Oxford and Principal Investigator on the study.

In some cases, the treatment for DCIS is total mastectomy as it is curative in nearly all patients1. However, t
'"/>

Contact: Vanessa Leon
vanessa.leon@edelman.com
44-207-344-1344
Edelman Public Relations
8-Aug-2007


Page: 1 2

Related biology news :

1. Almac Diagnostics attends pre-IDE meeting with FDA
2. Almac Diagnostics announces pioneering genetic research on colorectal pre-malignancies
3. ESA announces 2007 award recipients
4. President Bush announces 2005 and 2006 Laureates of National Medals of Science and Technology
5. Conservation Leadership Program announces 2007 awardees
6. ACMG Foundation announces 2007-2008 Luminex/ACMGF award recipient
7. Revolutionary global environment fund announces $50M expansion
8. Biovest announces interim blinded data of fast-tracked pivotal Phase 3 clinical trial of BiovaxID
9. Cell Press announces new partnership with the American Society of Human Genetics
10. ChemGenex announces publication confirming activity of Ceflatonin in T315I-Positive CML
11. Minister Lunn announces $39.6M for next phase of mountain pine beetle response

Post Your Comments:
*Name:
*Comment:
*Email:


(Date:8/14/2019)... ... August 14, 2019 , ... Gateway Genomics , a leading ... inclusion in the 38th annual Inc. 500|5000 list of fastest growing private ... companies must have been founded and generating revenue by March 31, 2015. Ranking in ...
(Date:8/14/2019)... ... ... Julie Reck of Veterinary Medical Center of Fort Mill has recently begun providing ... her own geriatric Australian Shepherd, Simon, was treated in June 2019 for osteoarthritis in his ... body was weak, and he struggled to play fetch and other games with his family. ...
(Date:8/6/2019)... ... August 06, 2019 , ... A study released today in ... far-reaching implications for personalized medicine, especially when seeking treatments for children with heart ... which stem cell donors and manipulation methods might yield the best therapies for ...
Breaking Biology News(10 mins):
(Date:9/11/2019)... (PRWEB) , ... September 09, 2019 , ... ... life sciences companies and government agencies, announced that its president and CEO Maryann ... of successful business leaders. , The Forbes Council accepted Gallivan based on the ...
(Date:9/8/2019)... YORK (PRWEB) , ... September 04, 2019 , ... ... New York Academy of Sciences announced today the three Winners and six ... outstanding postdoctoral scientists from academic research institutions across New York, New Jersey, and ...
(Date:8/29/2019)... ... August 28, 2019 , ... DuPont Nutrition & Biosciences will ... at the International Baking Industry Expo, September 8 to 11, in booth 5015. ... to cost and waste reduction and from maintaining freshness throughout shelf life to ...
(Date:8/23/2019)... ... ... The EnozoPro® converts ordinary tap water into a sanitizing spray capable of ... including E. Coli, Salmonella, MRSA, Listeria and Legionella. It works as a cleaner, sanitizer ... page at rovingblue.com , ”At Enozo, our mission is to develop solutions to replace ...
Breaking Biology Technology:
Cached News: